Zenas BioPharma, Inc. (ZBIO)
20.25
+0.32
(+1.61%)
USD |
NASDAQ |
Jan 16, 14:58
Zenas BioPharma EPS Diluted (Quarterly): -1.222 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| Royalty Pharma Plc | 0.6654 |
| Nektar Therapeutics | -1.875 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.50M |
| Total Expenses (Quarterly) | 51.50M |
| Enterprise Value | 543.67M |
| Earnings Yield | -22.37% |
| Normalized Earnings Yield | -21.96 |